Dominique Bordessoule

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

P. Gaulard, C. Gisselbrecht, É. Lepage, 2001, The hematology journal : the official journal of the European Haematology Association.

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT).

W. Stevens, M. Pfreundschuh, C. Sebban, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic Transplantation for Patients with Advanced Acute Leukemia: a Single Center Retrospective Study of 92 Patients

P. Cony-Makhoul, J. Reiffers, G. Marit, 2001, Leukemia & lymphoma.

L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature.

P. Gaulard, B. Petit, R. Gressin, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.

H. Tilly, N. Brousse, C. Sebban, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.

F. Berger, C. Sebban, É. Lepage, 2000, Blood.

Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I study of the anti-natural killer inhibitory receptor (KIR) monoclonal antibody (1-7F9, IPH2101) in elderly patients with acute myeloid leukemia (AML).

H. Dombret, D. Blaise, N. Vey, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.